Letter: is it appropriate to use a fatty liver index >60 as an alternative criterion for non-alcoholic fatty liver disease? Authors' reply

Affiliations

¹ Institute of Nutrition of Central America and Panama (INCAP) Research Center for the Prevention of Chronic Diseases, Institute of Nutrition of Central America and Panama, Guatemala City, Guatemala.
² Slone Epidemiology Center, Boston University, Boston, Massachusetts, USA.
³ Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.
⁴ Department of Nutrition, Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts, USA.
⁵ Information Management Services, Colesville, Maryland, USA.
⁶ Department of General Internal Medicine, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
⁷ Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA.
⁸ Department of Environmental Health and Engineering, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA.

Comment

Alvaro Rivera-Andrade et al. Aliment Pharmacol Ther. 2022 Jul.

. 2022 Jul;56(2):378-379.

doi: 10.1111/apt.17060.

¹ Institute of Nutrition of Central America and Panama (INCAP) Research Center for the Prevention of Chronic Diseases, Institute of Nutrition of Central America and Panama, Guatemala City, Guatemala.
² Slone Epidemiology Center, Boston University, Boston, Massachusetts, USA.
³ Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.
⁴ Department of Nutrition, Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts, USA.
⁵ Information Management Services, Colesville, Maryland, USA.
⁶ Department of General Internal Medicine, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
⁷ Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA.
⁸ Department of Environmental Health and Engineering, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA.

No abstract available

Comment on

Circulating bile acid concentrations and non-alcoholic fatty liver disease in Guatemala.
Rivera-Andrade A, Petrick JL, Alvarez CS, Graubard BI, Florio AA, Kroker-Lobos MF, Parisi D, Freedman ND, Lazo M, Guallar E, Groopman JD, Ramirez-Zea M, McGlynn KA. Rivera-Andrade A, et al. Aliment Pharmacol Ther. 2022 Jul;56(2):321-329. doi: 10.1111/apt.16948. Epub 2022 Apr 28. Aliment Pharmacol Ther. 2022. PMID: 35484638 Free PMC article.
Letter: is it appropriate to use a fatty liver index >60 as an alternative criterion for non-alcoholic fatty liver disease?
Li XZ, Zhu JQ, Zhang SY, He QQ, Zhang GX, Jia HD, Wang XM. Li XZ, et al. Aliment Pharmacol Ther. 2022 Jul;56(2):376-377. doi: 10.1111/apt.17041. Aliment Pharmacol Ther. 2022. PMID: 35748848 No abstract available.

1. Li X-Z, Zhu J-Q, Zhang S-Y, He Q-Q, Zhang G-X, Jia H-D, et al. Letter: is it appropriate to use a fatty liver index >60 as an alternative criterion for non-alcoholic fatty liver disease? Aliment Pharmacol Ther. 2022;56:375-376.
1. Rivera-Andrade A, Petrick JL, Alvarez CS, Graubard BI, Florio AA, Kroker-Lobos MF, et al. Circulating bile acid concentrations and non-alcoholic fatty liver disease in Guatemala. Aliment Pharmacol Ther. 2022;56:321-329.